Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J. Health Biol. Sci. (Online) ; 12(1): 1-15, jan.-dez. 2024. ilus, tab
Artículo en Inglés | LILACS | ID: biblio-1566673

RESUMEN

Objective: we evaluated the seroprevalence and levels of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies among medical students and the possible associated factors. Methods: a survey was conducted using the data collected in November 2020 and February 2022 in Fortaleza, Northeast Brazil. A questionnaire was administered, and blood and nasopharyngeal swab samples were collected. The Abbott test was used for the assessment of humoral response to the SARS-CoV-2 spike (S) and nucleocapsid (N) proteins. The total antibodies were detected using a SARS-CoV-2 antibody test (Wodfo). Swab samples were subjected to qualitative detection of viral RNA. Chi-square test and multinomial logistic regression analysis were performed using SPSS and GraphPad Prism. Results: the seroprevalence rate in 2020 was 6.22% (40/643), and no difference in prevalence was observed between the semesters (p=0.520). The seroconversion rate was 51.1%. The seropositivity rates were 48.9% for N antibodies and 100% for S antibodies. The antibody response to N protein was higher in 2022 (p<0.001). Loss of smell was the most prevalent positive symptom (p=0.032). The adherence rate to protection measures was >75%. Most students reported a decrease in family income (63.7%), an increase in anxiety (82.6%), and a negative impact on their mental health (85.7%) regardless of the seroconversion status. The worst indicators of mental health quality were observed in students who attended classes up to the eighth semester (p<0.001). Conclusion: students showed lower immune response than the general population, with excellent adherence to the preventive and control measures. Medical schools played an important role in the formation but not transmission.


Objetivo: avaliamos a soroprevalência e os níveis de anticorpos anti-síndrome respiratória aguda grave coronavírus 2 (SARS-CoV-2) entre estudantes de medicina e os possíveis fatores associados. Métodos: foi realizada uma pesquisa com dados coletados em novembro de 2020 e fevereiro de 2022 em Fortaleza, Nordeste do Brasil. Um questionário foi aplicado e amostras de sangue e swab nasofaríngeo foram coletadas. O teste de Abbott foi utilizado para avaliação da resposta humoral às proteínas spike (S) e nucleocapsídeo (N) do SARS-CoV-2. Os anticorpos totais foram detectados usando um teste de anticorpos SARS-CoV-2 (Wodfo). Amostras de swab foram submetidas à detecção qualitativa de RNA viral. O teste qui-quadrado e a análise de regressão logística multinomial foram realizados utilizando SPSS e GraphPad Prism. Resultados: a taxa de soroprevalência em 2020 foi de 6,22% (40/643), e não foi observada diferença de prevalência entre os semestres (p=0,520). A taxa de soroconversão foi de 51,1%. As taxas de soropositividade foram de 48,9% para anticorpos N e 100% para anticorpos S. A resposta de anticorpos à proteína N foi maior em 2022 (p<0,001). A perda do olfato foi o sintoma positivo mais prevalente (p=0,032). A taxa de adesão às medidas de proteção foi >75%. A maioria dos estudantes relatou diminuição da renda familiar (63,7%), aumento da ansiedade (82,6%) e impacto negativo na saúde mental (85,7%), independentemente do estado de soroconversão. Os piores indicadores de qualidade em saúde mental foram observados nos alunos que frequentavam aulas até o oitavo semestre (p<0,001). Conclusão: os estudantes apresentaram resposta imunológica menor que a da população em geral, com excelente adesão às medidas preventivas e de controle. As escolas médicas desempenharam um papel importante na formação, mas não na transmissão.


Asunto(s)
Humanos , COVID-19 , Estudiantes de Medicina , ARN Viral
2.
Rev Soc Bras Med Trop ; 55: e06062021, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35522813

RESUMEN

BACKGROUND: The school community was heavily impacted by the Covid-19 pandemic, especially with the long time of school closures. This study aimed to analyze the seroprevalence of SARS-CoV-2 antibodies and possible factors associated with seropositivity for COVID-19 in teachers and other school staff, and to estimate the fraction of asymptomatic individuals by sex and age group. METHODS: We conducted a serological survey of SARS-CoV-2 infections. An analytical cross-sectional study was conducted in Fortaleza, Brazil. Teachers and other staff members from pre-schools to universities of higher education to were investigated. RESULTS: A total of 1,901 professionals participated in the study, of which 1,021 were staff and 880 were teachers. The seroprevalence of SARS-CoV-2 was 8.0% (152/1901). In the seropositive group, 48.3% were asymptomatic. There was a predominance of women (68.4%); and, 47.1% of the participants were between 31 and 45 years old. There was an increase in prevalence with increasing age. An inverse relationship was found for education level: more professionals with less education tested positive for COVID-19. The presence of an infected person living in the same household was significantly associated with positive results for COVID-19 among the professionals. CONCLUSIONS: This is the first study to report the seroprevalence of IgG against SARS-CoV-2 in Brazilian educational staff after the first wave of the disease. In this study, the seroprevalence was much lower than that in the general population. During school reopening, a small fraction of school workers showed serologically detectable signs of SARS-CoV-2 exposure.


Asunto(s)
COVID-19 , Adulto , Anticuerpos Antivirales , Brasil/epidemiología , COVID-19/epidemiología , Preescolar , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pandemias , SARS-CoV-2 , Estudios Seroepidemiológicos
3.
Rev. Soc. Bras. Med. Trop ; 55: e0606, 2022. tab
Artículo en Inglés | LILACS-Express | LILACS | ID: biblio-1376359

RESUMEN

ABSTRACT Background: The school community was heavily impacted by the Covid-19 pandemic, especially with the long time of school closures. This study aimed to analyze the seroprevalence of SARS-CoV-2 antibodies and possible factors associated with seropositivity for COVID-19 in teachers and other school staff, and to estimate the fraction of asymptomatic individuals by sex and age group. Methods: We conducted a serological survey of SARS-CoV-2 infections. An analytical cross-sectional study was conducted in Fortaleza, Brazil. Teachers and other staff members from pre-schools to universities of higher education to were investigated. Results: A total of 1,901 professionals participated in the study, of which 1,021 were staff and 880 were teachers. The seroprevalence of SARS-CoV-2 was 8.0% (152/1901). In the seropositive group, 48.3% were asymptomatic. There was a predominance of women (68.4%); and, 47.1% of the participants were between 31 and 45 years old. There was an increase in prevalence with increasing age. An inverse relationship was found for education level: more professionals with less education tested positive for COVID-19. The presence of an infected person living in the same household was significantly associated with positive results for COVID-19 among the professionals. Conclusions: This is the first study to report the seroprevalence of IgG against SARS-CoV-2 in Brazilian educational staff after the first wave of the disease. In this study, the seroprevalence was much lower than that in the general population. During school reopening, a small fraction of school workers showed serologically detectable signs of SARS-CoV-2 exposure.

4.
Acta Cir Bras ; 34(1): e20190010000009, 2019 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-30785510

RESUMEN

PURPOSE: To evaluate the contribution of ursodeoxycholic acid (UDCA) in the first 12 months after Roux-en-Y gastric bypass in the prevention of gallstone formation. METHODS: A community-based clinical trial was conducted. A total of 137 patients were included in the study; 69 were treated with UDCA, starting 30 days after the surgery, at a dose of 150 mg twice daily (300 mg/day) over a period of 5 consecutive months (GROUP A), and 68 were control patients (GROUP B). The patients were followed-up, and ultrasonography was performed to determine the presence of gallstones at various times during follow-up. Demographic, anthropometric and comorbid indicators were obtained. The data were subjected to normality tests and evaluated using appropriate tests. RESULTS: Patients did not differ in their baseline characteristics. Of the 69 patients who used UDCA, only one patient developed cholelithiasis (1%), whereas 18 controls (26%) formed gallstones (OR = 24.4, p <0.001). Also, other factors were found not to influence the formation of calculi, such as pre-operative or postoperative hepatic steatosis or diabetes (p = 0.759, 0.468, 0.956). CONCLUSION: The results demonstrated that patients who did not use UDCA showed a 24.4-fold greater probability of developing cholelithiasis.


Asunto(s)
Colagogos y Coleréticos/uso terapéutico , Cálculos Biliares/prevención & control , Derivación Gástrica/efectos adversos , Obesidad Mórbida/cirugía , Complicaciones Posoperatorias/prevención & control , Ácido Ursodesoxicólico/uso terapéutico , Adulto , Antropometría , Comorbilidad , Femenino , Cálculos Biliares/tratamiento farmacológico , Cálculos Biliares/etiología , Humanos , Masculino , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/etiología , Periodo Posoperatorio , Estudios Prospectivos , Estómago/cirugía
5.
Acta cir. bras ; 34(1): e20190010000009, 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-983686

RESUMEN

Abstract Purpose: To evaluate the contribution of ursodeoxycholic acid (UDCA) in the first 12 months after Roux-en-Y gastric bypass in the prevention of gallstone formation. Methods: A community-based clinical trial was conducted. A total of 137 patients were included in the study; 69 were treated with UDCA, starting 30 days after the surgery, at a dose of 150 mg twice daily (300 mg/day) over a period of 5 consecutive months (GROUP A), and 68 were control patients (GROUP B). The patients were followed-up, and ultrasonography was performed to determine the presence of gallstones at various times during follow-up. Demographic, anthropometric and comorbid indicators were obtained. The data were subjected to normality tests and evaluated using appropriate tests. Results: Patients did not differ in their baseline characteristics. Of the 69 patients who used UDCA, only one patient developed cholelithiasis (1%), whereas 18 controls (26%) formed gallstones (OR = 24.4, p <0.001). Also, other factors were found not to influence the formation of calculi, such as pre-operative or postoperative hepatic steatosis or diabetes (p = 0.759, 0.468, 0.956). Conclusion: The results demonstrated that patients who did not use UDCA showed a 24.4-fold greater probability of developing cholelithiasis.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Complicaciones Posoperatorias/prevención & control , Ácido Ursodesoxicólico/uso terapéutico , Obesidad Mórbida/cirugía , Colagogos y Coleréticos/uso terapéutico , Derivación Gástrica/efectos adversos , Cálculos Biliares/prevención & control , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/tratamiento farmacológico , Periodo Posoperatorio , Estómago/cirugía , Cálculos Biliares/etiología , Cálculos Biliares/tratamiento farmacológico , Comorbilidad , Antropometría , Estudios Prospectivos
6.
Acta Cir Bras ; 30(1): 24-33, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25627268

RESUMEN

PURPOSE: To evaluate the effect of propranolol on capsular architecture around silicone implants by measuring the inflammation, capsular thickness, and collagen fiber density, using a guinea pig experimental model. METHODS: Thirty six adult male guinea pigs randomly divided into two groups (n=18) were used. Each one received a silicone implant with textured-surface. The capsular tissue around implants from untreated or treated animals with the beta-adrenoceptor antagonist propranolol (10 mg/kg, dissolved in daily water) were analyzed for inflammation by histological scoring, capsular thickness by computerized histometry, and collagen fibers type I and Type III density by picrosirius polarization at different time points (7, 14 or 21 days after silicone implantation). RESULTS: Propranolol treatment reduced inflammation and impaired capsular thickness and delayed collagen maturation around the textured implant. CONCLUSION: Propranolol reduces the risk of developing capsular contracture around silicone implants with textured surface.


Asunto(s)
Antagonistas Adrenérgicos beta/farmacología , Contractura Capsular en Implantes/prevención & control , Propranolol/farmacología , Geles de Silicona/efectos adversos , Antagonistas Adrenérgicos beta/uso terapéutico , Animales , Implantes de Mama/efectos adversos , Colágeno Tipo I/análisis , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo III/análisis , Colágeno Tipo III/efectos de los fármacos , Modelos Animales de Enfermedad , Cobayas , Humanos , Contractura Capsular en Implantes/patología , Implantes Experimentales/efectos adversos , Masculino , Propranolol/uso terapéutico , Distribución Aleatoria , Reproducibilidad de los Resultados , Tejido Subcutáneo/efectos de los fármacos , Tejido Subcutáneo/patología , Factores de Tiempo , Resultado del Tratamiento
7.
Acta cir. bras ; 30(1): 24-33, 01/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-735711

RESUMEN

PURPOSE: To evaluate the effect of propranolol on capsular architecture around silicone implants by measuring the inflammation, capsular thickness, and collagen fiber density, using a guinea pig experimental model. METHODS: Thirty six adult male guinea pigs randomly divided into two groups (n=18) were used. Each one received a silicone implant with textured-surface. The capsular tissue around implants from untreated or treated animals with the beta-adrenoceptor antagonist propranolol (10 mg/kg, dissolved in daily water) were analyzed for inflammation by histological scoring, capsular thickness by computerized histometry, and collagen fibers type I and Type III density by picrosirius polarization at different time points (7, 14 or 21 days after silicone implantation). RESULTS: Propranolol treatment reduced inflammation and impaired capsular thickness and delayed collagen maturation around the textured implant. CONCLUSION: Propranolol reduces the risk of developing capsular contracture around silicone implants with textured surface. .


Asunto(s)
Animales , Cobayas , Humanos , Masculino , Antagonistas Adrenérgicos beta/farmacología , Contractura Capsular en Implantes/prevención & control , Propranolol/farmacología , Geles de Silicona/efectos adversos , Antagonistas Adrenérgicos beta/uso terapéutico , Implantes de Mama/efectos adversos , Colágeno Tipo I/análisis , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo III/análisis , Colágeno Tipo III/efectos de los fármacos , Modelos Animales de Enfermedad , Contractura Capsular en Implantes/patología , Implantes Experimentales/efectos adversos , Propranolol/uso terapéutico , Distribución Aleatoria , Reproducibilidad de los Resultados , Tejido Subcutáneo/efectos de los fármacos , Tejido Subcutáneo/patología , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA